Financials data is unavailable for this security.
View more
Year on year Ajooni Biotech Ltd grew revenues 7.55% from 744.88m to 801.15m while net income improved 92.17% from 11.25m to 21.61m.
| Gross margin | 12.72% |
|---|---|
| Net profit margin | 2.62% |
| Operating margin | 1.94% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Ajooni Biotech Ltd increased its cash reserves by 38.44%, or 1.19m. Cash Flow from Investing totalled 76.37m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 39.52m for operations while cash used for financing totalled 35.66m.
| Cash flow per share | 0.2771 |
|---|---|
| Price/Cash flow per share | 41.04 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 94.73%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| EPS growth(5 years) | 18.73 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 31.80 |
